InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Stonehouse Jon P, Chairman & CEO. Director active across 3 companies, notably Biocryst Pharmaceuticals INC. Cumulatively, 33 disclosures have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €298k. Activity tracked since 1 September 2021. The latest transaction was disclosed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Stonehouse Jon P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
15,294 sharesCommon StockSEC:0000882796-26-000039:0
631 shares@ US$8.910.0002% mcap0.2% of flowCommon StockSEC:0000882796-26-000031:0
421 shares@ US$8.750.1% of flowCommon StockSEC:0000882796-26-000011:0
61,793 shares@ US$7.4113.1% of flowCommon StockSEC:0000882796-25-000045:0
20,000 shares0Common StockSEC:0001171843-25-008039:0
27,368 shares@ US$7.577.4% of flowCommon StockSEC:0000882796-25-000031:0
2,688 sharesCommon StockSEC:0001193125-25-280798:0
14,010 shares@ US$7.393.3% of flowCommon StockSEC:0001127602-24-029948:1
362,100 shares0Common StockSEC:0001127602-24-029948:0
20,000 shares0Common StockSEC:0001127602-24-029948:2
10,000 shares0Common StockSEC:0001127602-24-029948:3
10,000 shares0Common StockSEC:0001127602-24-029948:4
27,525 shares@ US$7.536.6% of flowCommon StockSEC:0001127602-24-029592:0
30,000 shares@ US$5.555.2% of flowCommon StockSEC:0001127602-24-015365:0
Canonical exit: 11 Aug 2024 (T+90)
20,000 shares0Common StockSEC:0001127602-24-000832:0
14,089 shares@ US$6.052.6% of flowCommon StockSEC:0001127602-23-030187:0
127,500 shares0Common StockSEC:0001127602-23-029835:0
25,000 shares0Common StockSEC:0001171843-23-003946:0
31,055 shares@ US$3.223.1% of flowCommon StockSEC:0001127602-23-011193:0
10,000 shares0Common StockSEC:0001127602-23-003172:0
121,452 shares0Common StockSEC:0001628280-23-000419:0
60,580 shares0Common StockSEC:0001628280-23-000354:0
127,500 shares0Common StockSEC:0001127602-22-028080:0
14,100 shares@ US$10.904.8% of flowCommon StockSEC:0001127602-22-027894:0
214,917 shares@ US$1.429.8% of flowCommon StockSEC:0001127602-22-026832:0
25 of 33 declarations
About Stonehouse Jon P
Stonehouse Jon P is Président-Directeur Général, Administrateur. He has 33 filings in total, and across the sampled 33 filings, the reported cumulative amounts are EUR 154259 in buys and EUR 143954 in sells, with filings dated from 2016-01-05 to 2026-06-15. The most frequent transaction type is Levée d'options; the companies mentioned are Biocryst Pharmaceuticals INC, Bellicum Pharmaceuticals, INC and Metsera, Inc.
